PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS

PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS

Analysis of  four pharmacoeconomic replacement models for  midazolam, propofol and  phentanyl with dexmedetomidine for sedation in resuscitation and intensive care unit (RICU) shows increase of the annual costs (at current prices) by 14-28 million rubles (at prices of the reference country – by 9-23...

Full description

Bibliographic Details
Main Authors: S. L. Plavinskiy, P. I. Shabalkin, A. E. Karelov
Format: Article
Language:Russian
Published: New Terra Publishing House 2017-11-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
декcмедетомидин
седация в орит
фармакоэкономический анализ
бюджетные расходы
возмещение расходов
dexmedetomidine
sedation in ricu
pharmaco-economic analysis
budget costs
cost reimbursement
Online Access:https://www.vair-journal.com/jour/article/view/60

Internet

https://www.vair-journal.com/jour/article/view/60

Similar Items